Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma
Clinical trial NCT01655693 · COMPLETED
Trial details
- NCT number
- NCT01655693
- Sponsor
- Valerio Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2017-05-01
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.